This study is a multicentra, prospective study. The enrolled patients are HP positive. They are diagnosed as HP positive by rapid urease test and/or 13C urea breath test. According to the declaration of Helsinki, 200 patients will be included in this study. After obtaining the written informed consent of the patients, HP culture and drug sensitivity test will be conducted on all the selected patients with the success rate, adverse reactions, compliance, antibiotic resistance of HP and its impact on HP eradication.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
Potassium competitive acid blocker
Antibiotics for H. pylori eradication
Gastric mucosal protective drug with anti-H. pylori effect
Antibiotics for H. pylori eradication
Hebi People's Hospital
Hebi, Henan, China
RECRUITINGJiaozuo People's Hospital
Jiaozuo, Henan, China
RECRUITINGLuoyang central Hospital
Luoyang, Henan, China
RECRUITINGThe first people's hospital of ping ding shan
Pingdingshan, Henan, China
RECRUITINGXuchang central Hospital
Xuchang, Henan, China
RECRUITINGThe Second Affiliated Hospital of Henan University of science and technology
Zhengzhou, Henan, China
RECRUITINGThe Third People's Hospital of Zhengzhou
Zhengzhou, Henan, China
RECRUITINGZhengzhou People's Hospital
Zhengzhou, Henan, China
RECRUITINGZhoukou Central Hospital
Zhoukou, Henan, China
RECRUITINGRenji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China
RECRUITINGHelicobacter pylori eradication rate
Six weeks after completion of therapy, H. pylori eradication was assessed by ¹³C-urea breath test. Eradication was defined as negative result from urea breath test (\<4‰) (4‰ as the cutoff value).
Time frame: Six weeks after completion of therapy
Rate of adverse effects
The subjects were asked to grade the severity of adverse events according to their influence on daily activities, experienced as "mild" (transient and well tolerated), "moderate" (causing discomfort and partially interfering with daily activities), or "severe" (causing considerable interference with daily activities)
Time frame: Within 7 days after completion of therapy
Compliance rate
Compliance was defined as poor when they had taken less than 80% of the total medication
Time frame: Within 7 days after completion of therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.